These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 33796055

  • 1. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
    Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J.
    Front Psychol; 2021; 12():645246. PubMed ID: 33796055
    [Abstract] [Full Text] [Related]

  • 2. Compassionate use of psychedelics.
    Greif A, Šurkala M.
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [Abstract] [Full Text] [Related]

  • 3. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B, Luoma JB, Bathje GJ, Rhea J, Narloch VF.
    Harm Reduct J; 2021 Apr 07; 18(1):40. PubMed ID: 33827588
    [Abstract] [Full Text] [Related]

  • 4. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
    Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW.
    Front Psychol; 2022 Apr 07; 13():873279. PubMed ID: 35677124
    [Abstract] [Full Text] [Related]

  • 5.
    Chao YS, Horton J.
    ; 2021 06 07. PubMed ID: 36170470
    [Abstract] [Full Text] [Related]

  • 6. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T, Amada N, Jungaberle H, Schecke H, Klein M.
    Int J Drug Policy; 2020 Jan 07; 75():102600. PubMed ID: 31778967
    [Abstract] [Full Text] [Related]

  • 7. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS, Aaronson ST.
    Curr Psychiatry Rep; 2022 Oct 07; 24(10):583-590. PubMed ID: 36129571
    [Abstract] [Full Text] [Related]

  • 8. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS, Dike CC.
    Psychiatr Serv; 2023 Aug 01; 74(8):838-846. PubMed ID: 36987705
    [Abstract] [Full Text] [Related]

  • 9. Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.
    Mocanu V, Mackay L, Christie D, Argento E.
    Subst Abuse Treat Prev Policy; 2022 May 14; 17(1):37. PubMed ID: 35568884
    [Abstract] [Full Text] [Related]

  • 10. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.
    Sekula AD, Downey L, Puspanathan P.
    Front Psychol; 2022 May 14; 13():813746. PubMed ID: 35310225
    [Abstract] [Full Text] [Related]

  • 11. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
    Kruger DJ, Glynos NG, Fields CW, Herberholz M, Boehnke KF.
    J Psychoactive Drugs; 2023 May 14; 55(4):420-424. PubMed ID: 36328419
    [Abstract] [Full Text] [Related]

  • 12. Psychedelics and Psychotherapy.
    Nayak S, Johnson MW.
    Pharmacopsychiatry; 2021 Jul 14; 54(4):167-175. PubMed ID: 33285578
    [Abstract] [Full Text] [Related]

  • 13. Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.
    De La Haye W, Walcott G, Eaton J, Beckford J, Greene J.
    Front Psychiatry; 2023 Jul 14; 14():1136990. PubMed ID: 37457761
    [Abstract] [Full Text] [Related]

  • 14. Back from the rabbit hole. Theoretical considerations and practical guidelines on psychedelic integration for mental health specialists.
    Greń J, Tylš F, Lasocik M, Kiraly C.
    Front Psychol; 2023 Jul 14; 14():1054692. PubMed ID: 37904908
    [Abstract] [Full Text] [Related]

  • 15. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
    Greenway KT, Garel N, Jerome L, Feduccia AA.
    Expert Rev Clin Pharmacol; 2020 Jun 14; 13(6):655-670. PubMed ID: 32478631
    [Abstract] [Full Text] [Related]

  • 16. The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.
    Frymann T, Whitney S, Yaden DB, Lipson J.
    Front Psychol; 2022 Jun 14; 13():863247. PubMed ID: 35677137
    [Abstract] [Full Text] [Related]

  • 17. Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.
    Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS.
    Int J Drug Policy; 2021 Dec 14; 98():103380. PubMed ID: 34329952
    [Abstract] [Full Text] [Related]

  • 18. Psychedelics and neonihilism: connectedness in a meaningless world.
    Plesa P, Petranker R.
    Front Psychol; 2023 Dec 14; 14():1125780. PubMed ID: 37621941
    [Abstract] [Full Text] [Related]

  • 19. Attitudes of European psychiatrists on psychedelics: a qualitative study.
    Žuljević MF, Breški N, Kaliterna M, Hren D.
    Front Psychiatry; 2024 Dec 14; 15():1411234. PubMed ID: 38855648
    [Abstract] [Full Text] [Related]

  • 20. Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
    Gardner J, Carter A, O'Brien K, Seear K.
    Int J Drug Policy; 2019 Aug 14; 70():94-98. PubMed ID: 31136924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.